瘤微环境触发的自适应聚合物光敏感剂用于增强光动力学治疗
Zepeng Cui1, Ruqian Ji1, Jun Xie1
1Shanghai Key Laboratory of Functional Materials Chemistry, School of Chemistry and Molecular Engineering, East China University of Science and Technology, Shanghai 200237, China.
Biomacromolecules
|March 20, 2024
概括
这项研究引入了一种自适应纳米平台,使用基于的氧化来减少光敏剂聚合,增强光动力疗法 (PDT) 进行瘤切除,并将副作用降到最低.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 光动力疗法 (PDT) 是一种有前途的非侵入性瘤切除技术.
- 由于光敏感剂聚合和π-π堆叠,PDT的有效性受到限制.
- 需要新的策略来提高光敏感剂在PDT中的性能.
研究的目的:
- 开发一个瘤微环境触发的自我适应纳米平台,以克服光敏剂聚合.
- 增强单片氧 (O2) 生成,以提高PDT的疗效.
- 调查PSE纳米平台在固体瘤治疗中的治疗潜力.
主要方法:
- 一种含有的氨酸含氨酸的两性共聚合物 (PSe) 的合成.
- 利用基氧化在瘤微环境中的纳米平台自我适应.
- 评估PSe纳米平台用于PDT的体外和体内性能.
主要成果:
- 通过氧化化到氧化单位,PSE纳米平台在瘤部位表现出自我适应.
- 这种自我适应减少了氨酸聚合,增加了单元之间的距离.
- 观察到增强的O2生成,在体内研究中导致显著的瘤切除.
结论:
- 通过瘤微环境触发的自我适应,PSE纳米平台有效地减轻了光敏剂聚合.
- 这种方法显著提高光动力学治疗对固体瘤的疗效.
- 开发的纳米平台显示了减少与PDT相关的副作用的潜力.
更多相关视频
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
9.0K
11:04An In-House-Built and Light-Emitting-Diode-Based Photodynamic Therapy Device for Enhancing Verteporfin Cytotoxicity in a 2D Cell Culture Model
Published on: January 13, 2023
3.0K
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
